Group One Trading
VRNA

Group One Trading’s Verona Pharma VRNA Stock Holding History

Group One Trading’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-49,577
Closed -$1.86M – 8032
2024
Q3 		$1.43M Buy
49,577
+47,312
+2,089% +$1.16M ﹤0.01% 2005
2024
Q2 		$32.8K Sell
2,265
-10,407
-82% -$152K ﹤0.01% 4849
2024
Q1 		$204K Buy
12,672
+1,245
+11% +$21.5K ﹤0.01% 3546
2023
Q4 		$227K Sell
11,427
-690
-6% -$10.2K ﹤0.01% 3760
2023
Q3 		$198K Buy
12,117
+3,257
+37% +$62.7K ﹤0.01% 3812
2023
Q2 		$187K Buy
+8,860
New +$189K ﹤0.01% 4002
2023
Q1 		– Sell
-39,372
Closed -$850K – 8028
2022
Q4 		$1.03M Buy
39,372
+34,155
+655% +$455K ﹤0.01% 2379
2022
Q3 		$53K Buy
5,217
+5,138
+6,504% +$43.3K ﹤0.01% 5369
2022
Q2 		$0 Hold
79
– – ﹤0.01% 8594
2022
Q1 		$0 Hold
79
– – ﹤0.01% 8788
2021
Q4 		$1K Buy
+79
New +$404 ﹤0.01% 8036

Other funds holding VRNA

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Group One Trading's VRNA Position: Q4 2024 in Review

Group One Trading sold out of Verona Pharma (VRNA) in Q4 2024, closing a stake of 49,577 shares — an estimated $1.86M sold.

Group One Trading first reported a position in VRNA in Q4 2021 and held it in 11 quarters. The position peaked at $1.43M in Q3 2024. 191 funds tracked by Wall St. Rank hold VRNA as of Q4 2024.

  • Group One Trading reported no remaining Verona Pharma position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 49,577 Verona Pharma shares in Q4 2024, an estimated $1.86M.
  • Group One Trading first reported a position in Verona Pharma in Q4 2021 and held it in 11 quarters.
  • Group One Trading's Verona Pharma position peaked at $1.43M in Q3 2024.
  • 191 funds tracked by Wall St. Rank held Verona Pharma as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.